Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting-Reference-Cited by-同舟云学术

Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting

Published:2018-04-13 Issue:4 Volume:19 Page:1192
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Mabeta Peace^ORCID

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/19/4/1192/pdf

Reference84 articles.

1. Reply

2. Basic science and clinical aspects of vascular anomalies

3. Hemangiomas - current therapeutic strategies

4. Infantile Hemangioma: New Insights on Pathogenesis and β Blockers Mechanisms of Action;Greenberger,2017

5. Propranolol represses infantile hemangioma cell growth through the β2-adrenergic receptor in a HIF-1α-dependent manner

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infantile hemangioma models: is the needle in a haystack?;Journal of Translational Medicine;2023-05-06

2. Multiple Capillary Hemangiomas of the Lung with Multi-Organ Involvement;Respiration;2023

3. Shikonin reverses pyruvate kinase isoform M2‐mediated propranolol resistance in infantile hemangioma through reactive oxygen species‐induced autophagic dysfunction;Cancer Science;2022-11-29

4. Identification of novel potential biomarkers in infantile hemangioma via weighted gene co-expression network analysis;BMC Pediatrics;2022-05-01

5. NOGOB receptor–mediated RAS signaling pathway is a target for suppressing proliferating hemangioma;JCI Insight;2021-02-08